The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5531272 6465252 F 1 5531272-8 20071011 20071114 20071127 EXP TH-JNJFOC-20071006902 MGI PHARMA, INC. F N 20071121 MD THAILAND

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5531272 1009214417 PS DECITABINE (DECITABINE) LYOPHILIZED POWDER 2 INTRAVENOUS 29 MG, INTRAVENOUS; 29 MG, INTRAVENOUS D D 21790
5531272 1009244579 C SODAMINT (SODIUM BICARBONATE) UNSPECIFIED) 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
5531272 1009214417 MYELODYSPLASTIC SYNDROME

Outcome of event

Event ID OUTC COD
5531272 HO

Reactions reported

Event ID PT
5531272 ABDOMINAL PAIN
5531272 COLITIS
5531272 DIARRHOEA
5531272 HYPOTENSION
5531272 NEUTROPHIL COUNT DECREASED
5531272 PYREXIA
5531272 WHITE BLOOD CELL COUNT DECREASED

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5531272 FGN
5531272 HP
5531272 SDY

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5531272 1009214417 20070815 20070819
5531272 1009214417 20070912 20070916